BILIRUBIN – (Serum) Liver Function Test at Dr. Essa Lab

BILIRUBIN – (Serum) at Dr. Essa Lab

The BILIRUBIN – (Serum) test is a fundamental biochemical assessment used to measure the levels of bilirubin in the blood. Bilirubin is a yellowish-orange pigment produced during the normal physiological breakdown of red blood cells. Specifically, when senescent red blood cells are destroyed in the spleen, hemoglobin is catabolized into heme and globin. The heme portion is further degraded into biliverdin, which is then reduced to unconjugated (indirect) bilirubin. This unconjugated bilirubin is hydrophobic and travels through the bloodstream bound to albumin to reach the liver. Once inside the hepatocytes, the enzyme uridine diphosphate-glucuronosyltransferase (UGT) conjugates bilirubin with glucuronic acid, rendering it water-soluble. This conjugated (direct) bilirubin is then excreted into the bile canaliculi, stored in the gallbladder, and eventually released into the small intestine to assist in digestion before being excreted in feces and urine.

Measuring serum bilirubin is of paramount clinical importance for evaluating hepatobiliary function, identifying hemolytic disorders, and diagnosing the underlying causes of jaundice (icterus). At Dr. Essa Lab, the leading diagnostic network in Karachi, Pakistan, the BILIRUBIN – (Serum) test is performed using state-of-the-art fully automated clinical chemistry analyzers. These advanced systems utilize highly sensitive spectrophotometric and diazo methods to deliver exceptionally precise measurements of total, direct, and indirect bilirubin fractions. This diagnostic accuracy is vital for clinical decision-making, allowing hepatologists, gastroenterologists, pediatricians, and general physicians to formulate targeted treatment plans. By choosing Dr. Essa Lab, patients benefit from international-standard quality control, rapid turnaround times, and highly reliable diagnostic reports interpreted by experienced consultant pathologists.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest accuracy of your BILIRUBIN – (Serum) test results, proper pre-analytical preparation is essential. Patients are advised to adhere to the following preparation guidelines:

• Fasting Requirements: Adults are generally required to fast for 4 to 8 hours before the blood draw. Fasting means consuming no food or beverages other than plain water. Fasting is particularly important because lipemia (high fat concentration in the blood) resulting from recent food intake can interfere with the spectrophotometric analysis of bilirubin.
• Medication Review: Certain medications can artificially elevate or lower serum bilirubin levels. Inform your prescribing physician and the phlebotomist at Dr. Essa Lab if you are taking drugs such as phenobarbital, steroids, birth control pills, penicillin, salicylates, or high doses of Vitamin C. Do not discontinue any prescribed medication without consulting your doctor.
• Avoid Alcohol and Strenuous Exercise: Refrain from consuming alcohol and engaging in vigorous physical exercise for at least 24 hours before the test, as these activities can temporarily alter liver enzyme activity and bilirubin metabolism.
• Hydration: Stay well-hydrated by drinking adequate amounts of plain water before the procedure, as dehydration can falsely concentrate serum analytes.

During the Procedure

The BILIRUBIN – (Serum) test is a standard venipuncture procedure performed by highly trained phlebotomists at Dr. Essa Lab. The process is quick, safe, and minimally invasive:

• Patient Positioning: You will be asked to sit comfortably in a phlebotomy chair or lie down if you feel prone to lightheadedness.
• Site Selection and Cleansing: The phlebotomist will locate a suitable vein, typically in the antecubital fossa (the crook of the elbow). The skin over the selected vein is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) to prevent contamination.
• Tourniquet Application: A sterile elastic tourniquet is applied around the upper arm to restrict venous blood flow, causing the veins to engorge and become more visible and accessible.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube (typically a gold-top serum separator tube or a red-top clot activator tube) is gently inserted into the vein. You may feel a brief, mild pinch or prick.
• Sample Collection: The required volume of blood is drawn into the tube. For bilirubin testing, the sample must be protected from direct light immediately after collection, as light exposure can rapidly degrade bilirubin molecules, leading to falsely low results. Dr. Essa Lab utilizes amber-colored transport tubes or light-shielding wraps for this purpose.
• Post-Draw Care: Once the collection is complete, the tourniquet is released, the needle is gently withdrawn, and a sterile cotton ball or gauze is applied to the puncture site with mild pressure to stop any bleeding. A small adhesive bandage is then applied.
• Safety and Comfort: The entire process takes less than five minutes. The risks are minimal and limited to minor bruising, localized soreness, or very rarely, a brief feeling of faintness.

When is a BILIRUBIN – (Serum) Performed?

Investigating Jaundice and Yellowing of the Skin

Physicians routinely request a serum bilirubin test when a patient presents with clinical signs of jaundice, which is characterized by a distinct yellowish discoloration of the skin, sclera (the whites of the eyes), and mucous membranes. Jaundice occurs when bilirubin levels in the blood exceed normal physiological limits (typically above 2.5 to 3.0 mg/dL). Measuring the total and fractionated bilirubin helps clinicians determine whether the jaundice is pre-hepatic (due to excessive red blood cell breakdown), hepatic (due to liver cell damage), or post-hepatic (due to biliary tract obstruction).

Evaluating Liver Diseases and Hepatitis

The BILIRUBIN – (Serum) test is a core component of the Liver Function Test (LFT) panel. It is frequently ordered to evaluate patients suspected of having acute or chronic liver diseases, such as viral hepatitis (Hepatitis A, B, C, D, or E), alcoholic hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and cirrhosis. In these conditions, damaged hepatocytes lose their capacity to conjugate or properly excrete bilirubin, leading to its accumulation in the bloodstream. Monitoring bilirubin levels over time helps hepatologists assess the severity of liver injury and track the patient’s response to therapeutic interventions.

Monitoring Neonatal Jaundice in Newborns

Neonatal jaundice is an extremely common clinical condition in newborns, particularly in premature infants, occurring due to the developmental immaturity of the neonatal liver and the rapid breakdown of fetal red blood cells. Pediatricians closely monitor serum bilirubin levels in neonates to prevent a severe, potentially irreversible neurological complication known as kernicterus. Kernicterus occurs when excessively high levels of unconjugated bilirubin cross the blood-brain barrier, causing toxic damage to the basal ganglia and brainstem nuclei. Regular bilirubin testing guides the clinical use of phototherapy or exchange transfusions.

Assessing Hemolytic Anemia and Red Blood Cell Destruction

When a patient exhibits symptoms of anemia, such as chronic fatigue, weakness, pallor, and shortness of breath, a physician may order a serum bilirubin test to investigate hemolytic anemia. In hemolytic disorders, red blood cells are destroyed prematurely in the circulation or the spleen at a rate that exceeds the liver’s conjugating capacity. This results in a significant increase in unconjugated (indirect) bilirubin. Conditions such as sickle cell anemia, thalassemia, glucose-6-phosphate dehydrogenase (G6PD) deficiency, autoimmune hemolytic anemia, and incompatible blood transfusion reactions are common triggers for this clinical presentation.

Diagnosing Biliary Tract Obstruction and Gallstones

A serum bilirubin test is highly critical when a patient presents with symptoms suggestive of biliary obstruction, such as severe right upper quadrant abdominal pain, dark tea-colored urine, and pale, clay-colored stools (acholic stools). These symptoms indicate that conjugated bilirubin is blocked from flowing from the liver into the duodenum. Common causes of post-hepatic biliary obstruction include choledocholithiasis (gallstones in the common bile duct), benign biliary strictures, pancreatitis, and malignant tumors of the pancreas, gallbladder, or bile ducts. A marked elevation in conjugated (direct) bilirubin strongly points toward an obstructive etiology.

What Does a BILIRUBIN – (Serum) Detect?

The BILIRUBIN – (Serum) test is highly sensitive and detects a wide range of physiological abnormalities, hepatobiliary pathologies, and hematological disorders. Specifically, this test assists in the detection and monitoring of:

• Acute Viral Hepatitis: Inflammation of the liver parenchyma caused by hepatotropic viruses, leading to impaired bilirubin conjugation and excretion.
• Chronic Cirrhosis: Advanced, irreversible scarring of the liver tissue that severely compromises overall hepatic metabolic function.
• Toxic Hepatotoxicity: Liver injury induced by over-the-counter or prescription medications, herbal supplements, or chemical toxins (e.g., acetaminophen overdose).
• Alcoholic Liver Disease: Hepatic damage ranging from steatosis to alcoholic hepatitis and cirrhosis caused by chronic, excessive alcohol consumption.
• Choledocholithiasis: The presence of gallstones within the common bile duct, obstructing the physiological flow of bile.
• Pancreatic Head Adenocarcinoma: Malignant tumors of the head of the pancreas that compress the common bile duct, causing extrahepatic cholestasis.
• Gilbert’s Syndrome: A common, benign, hereditary genetic disorder characterized by mild, intermittent unconjugated hyperbilirubinemia due to reduced UGT1A1 enzyme activity.
• Crigler-Najjar Syndrome: A rare, severe genetic disorder characterized by a complete (Type I) or partial (Type II) deficiency of the bilirubin-conjugating enzyme.
• Dubin-Johnson Syndrome: A benign hereditary disorder characterized by impaired transport of conjugated bilirubin out of hepatocytes into the bile.
• Rotor Syndrome: A rare, benign hereditary condition similar to Dubin-Johnson syndrome, resulting in elevated conjugated bilirubin without liver pigmentation.
• Autoimmune Hepatitis: A chronic disease in which the body’s immune system attacks hepatocytes, causing progressive liver inflammation and dysfunction.
• Primary Biliary Cholangitis (PBC): An autoimmune destruction of the intrahepatic small bile ducts, leading to chronic cholestasis and liver scarring.
• Primary Sclerosing Cholangitis (PSC): A chronic cholestatic liver disease characterized by progressive inflammation and fibrotic strictures of both intrahepatic and extrahepatic bile ducts.
• Hemolytic Anemia: Accelerated destruction of erythrocytes, leading to an overproduction of unconjugated bilirubin.
• Incompatible Blood Transfusion Reaction: Acute immunological hemolysis occurring when a patient receives incompatible donor blood.
• Neonatal Physiological Jaundice: Transient jaundice in newborns due to immature hepatic conjugating mechanisms, resolving within a few weeks.
• Biliary Atresia: A congenital, life-threatening condition in infants characterized by the absence or abnormal narrowing of the extrahepatic biliary tree.
• Portal Hypertension: Elevated pressure within the portal venous system, often secondary to cirrhosis, affecting hepatic clearance of bilirubin.
• Congestive Hepatopathy: Liver congestion and dysfunction secondary to right-sided congestive heart failure.
• Severe Sepsis-Associated Cholestasis: Impaired bile secretion and bilirubin transport caused by systemic bacterial infections and circulating endotoxins.
• Wilson’s Disease: A rare genetic disorder of copper metabolism that can cause acute liver failure and severe hemolysis.
• Hemochromatosis: An iron overload disorder that damages liver cells, leading to progressive hepatic insufficiency.
• Non-Alcoholic Fatty Liver Disease (NAFLD): Accumulation of excess fat in liver cells not caused by alcohol, which can progress to cellular damage and mild hyperbilirubinemia.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is highly regarded across Pakistan for its efficiency, clinical accuracy, and patient-centric services. The turnaround time (TAT) for a routine BILIRUBIN – (Serum) test is exceptionally fast. In most clinical scenarios, the blood sample is processed, analyzed, and verified by a consultant pathologist within 4 to 6 hours of sample collection. This rapid reporting is crucial for urgent clinical decisions, especially in neonatal care and acute emergency settings.

Patients can access their diagnostic reports conveniently through multiple digital channels. Once the report is finalized, an automated SMS notification containing a direct, secure download link is sent to the patient’s registered mobile number. Reports can also be viewed and downloaded via the official Dr. Essa Lab website portal by entering the unique patient lab ID and password printed on the receipt. For enhanced convenience, physical copies of the reports can be collected from any of the numerous Dr. Essa Lab diagnostic centers located throughout Karachi and other major cities, or delivered directly to patients utilizing the home sample collection service.

BILIRUBIN – (Serum) Findings Overview

The following table outlines the typical parameters evaluated in a serum bilirubin test, along with their normal reference ranges and potential clinical implications of abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Total Bilirubin (Adults)	0.2 to 1.2 mg/dL	Elevated levels (>1.2 mg/dL) indicate hepatobiliary disease, hemolysis, or biliary tract obstruction.
Direct (Conjugated) Bilirubin	0.0 to 0.3 mg/dL	Elevated levels (>0.3 mg/dL) strongly suggest post-hepatic biliary obstruction, hepatitis, or cirrhosis.
Indirect (Unconjugated) Bilirubin	0.2 to 0.8 mg/dL	Elevated levels (>0.8 mg/dL) point toward hemolytic anemia, Gilbert’s syndrome, or transfusion reactions.
Neonatal Total Bilirubin (Term Infant)	< 5.0 mg/dL (within 24 hours of birth)	Significantly elevated levels (>15 mg/dL) require immediate clinical evaluation and phototherapy to prevent kernicterus.
Alanine Aminotransferase (ALT) Correlation	7 to 56 U/L (Typical reference range)	Concomitant elevation with bilirubin indicates acute hepatocellular injury (e.g., viral or toxic hepatitis).
Alkaline Phosphatase (ALP) Correlation	44 to 147 U/L (Typical reference range)	Concomitant marked elevation with conjugated bilirubin strongly indicates cholestasis or biliary obstruction.
Serum Albumin Correlation	3.5 to 5.0 g/dL (Typical reference range)	Decreased albumin levels alongside elevated bilirubin suggest chronic liver disease or severe nutritional deficiency.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for BILIRUBIN – (Serum)?

• Experienced Healthcare Professionals: Dr. Essa Lab features a highly qualified team of consultant pathologists, clinical biochemists, and medical technologists dedicated to diagnostic excellence.
• Patient-Focused Care: Every patient is treated with the utmost empathy, respect, and professional care, ensuring a comfortable and stress-free diagnostic experience.
• Quality Diagnostic Services: Operating under strict international quality standards, Dr. Essa Lab participates in rigorous external quality assurance programs.
• Professional Reporting: Reports are meticulously verified and signed by certified pathologists, ensuring high clinical reliability for your physician.
• Modern Diagnostic Approach: The laboratory utilizes fully automated, state-of-the-art clinical chemistry analyzers that minimize human error and maximize precision.
• Comfortable Environment: All collection centers are designed to maintain a clean, hygienic, and highly comfortable environment for patients of all ages.
• Convenient Location: With an extensive network of diagnostic centers across Karachi and other regions, finding a Dr. Essa Lab branch near you is effortless.
• Commitment to Accurate Diagnosis: Dr. Essa Lab has maintained a legacy of diagnostic trust and accuracy in Pakistan for over four decades, making it a preferred choice for families and clinicians alike.